The Endocannabinoid System Explained: How CB1, CB2, Anandamide, and 2-AG Regulate Homeostasis and Why Phytocannabinoids Work

If you cook with cannabis, you need to understand why it works in the human body at all. The answer is not THC itself. The answer is that your body already makes its own cannabis-like molecules and has a complete signaling system waiting for them.

What The Endocannabinoid System Is

The Endocannabinoid System or ECS was discovered in 1988-1992 after researchers tried to figure out how THC binds in the brain. It is a retrograde signaling system, meaning it works backwards compared to most neurotransmitters. Instead of a signal going forward from one neuron to the next, endocannabinoids are made on-demand in the postsynaptic neuron and travel backwards to tell the presynaptic neuron to slow down or stop releasing other neurotransmitters. It is a master brake pedal for homeostasis.

The ECS has three parts: receptors, endogenous ligands, and enzymes that build and break them.

CB1 and CB2 Receptors - Location Determines Effect

CB1 receptors are primarily G-protein coupled receptors located on neurons in the central nervous system. High density in the cerebral cortex, hippocampus, basal ganglia, and cerebellum. This maps directly to known cannabis effects: cognition and memory in cortex and hippocampus, motor control in cerebellum and basal ganglia, pain perception, mood, appetite, sleep, and stress response.

CB1 activation regulates neurotransmitter release. It does not directly excite or inhibit; it modulates how much GABA, glutamate, and dopamine are released by other systems.

CB2 receptors are primarily on immune cells, spleen, gastrointestinal tract, bone marrow, and peripheral tissue including skin. CB2 density in immune tissue explains why cannabinoids like CBD and CBG are studied for immune cell activation and inflammatory response regulation without strong intoxication. CB2 does not produce a high in the classical sense because it is largely absent from the cortical areas that drive intoxication.

The Ligands Your Body Makes: Anandamide and 2-AG

Anandamide or AEA is N-arachidonoylethanolamine. Derived from arachidonic acid plus ethanolamine. Sanskrit ananda means bliss. It is produced on-demand in cell membranes, binds partially to CB1, and is rapidly degraded by the enzyme FAAH, fatty acid amide hydrolase. Low, transient levels.

2-Arachidonoylglycerol or 2-AG is the most abundant endocannabinoid in the brain. Synthesized from diacylglycerol precursors, present at 100-1000x higher concentrations than anandamide. It is a full agonist at both CB1 and CB2 and is degraded by MAGL, monoacylglycerol lipase.

Both are made from membrane phospholipids, not stored in vesicles. This on-demand synthesis is why the system is about moment-to-moment regulation, not long-term storage.

Synthesis and Degradation Cycle

Synthesis: On-demand from membrane phospholipids when intracellular calcium rises

Binding: Endocannabinoids travel backwards across synapse and bind to CB1/CB2

Effect: G-protein cascade reduces neurotransmitter release, modulating pain, inflammation, appetite, mood

Degradation: FAAH breaks down anandamide, MAGL breaks down 2-AG

Cellular Uptake: Components reabsorbed into cells for recycling

This rapid build-and-break cycle is why endocannabinoid effects are local and short-lived, unlike phytocannabinoids from the plant which resist FAAH and MAGL and last hours.

Why Phytocannabinoids Work and Why Edibles Are Different

THC from cannabis is structurally similar enough to anandamide to bind CB1 as a partial agonist, but it is not broken down by FAAH quickly. It persists. When you inhale, THC goes to brain via lungs, onset 2-10 minutes.

When you eat cannabis, THC goes through first-pass liver metabolism. In the liver, cytochrome P450 enzymes convert delta-9-THC into 11-Hydroxy-THC, which is more potent, crosses the blood-brain barrier more efficiently, and has a longer half-life. This is why 10mg eaten can feel stronger and last 6-8 hours compared to 10mg inhaled for 2-3 hours, and why onset variability is 45-120 minutes depending on stomach contents, liver enzyme genetics, and fat content of the meal.

CBD does not bind CB1 strongly to cause intoxication. It inhibits FAAH, which raises your natural anandamide levels, and modulates CB2 immune signaling. This indirect mechanism explains dose-response differences.

Tolerance, Downregulation, and T-Break Science

Chronic high-dose CB1 activation causes receptor internalization. The cell pulls CB1 receptors inside to protect itself. Fewer surface receptors means you need more to feel the same effect. This is downregulation. Research shows CB1 density recovers after 48 hours to 28 days of abstinence, with most recovery in first 2 weeks. This is the biological basis for tolerance breaks.

Practical Takeaway for Education

Your body is not reacting to a foreign chemical. It is over-activating a system it already uses to balance pain, inflammation, mood, appetite, sleep, and stress. Dose, set, setting, liver metabolism, and whether you have eaten all change the outcome because they change how much reaches CB1/CB2 and how quickly FAAH and MAGL can clear it.

This is for educational purposes only. For adults 21+ where cannabis is legal. This is not medical advice. Effects vary. If you choose to consume, start low, go slow, and understand onset delay.